AMY FRANKLIN: Open Payments
NPI 1710963756 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 17 payments from 8 companies in 2025. Trend: 2023 $422 · 2024 $448 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 3 | $73 |
| Astellas Pharma US Inc | 4 | $63 |
| MILLICENT US INC | 3 | $52 |
| Sage Therapeutics, LLC | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Hologic Sales and Service, LLC | 1 | $30 |
| PFIZER INC. | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
Products named: NEXPLANON, Veozah, INTRAROSA, ZURZUVAE, MYFEMBREE, NOVASURE, FEMRING, ABRYSVO.
Industry payments across AL — which companies pay providers there.
